Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2026 08:00 ET | Source: Paratus Sciences Corporation

Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth

Bolstered leadership team positions Paratus to accelerate PS-1001 toward the clinic and build a pipeline of differentiated medicines.
April 17, 2026 08:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting

Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for Phase 3 development in DPNP New data on spasticity further...
April 16, 2026 10:34 ET | Source: Research and Markets

Measuring Performance in Clinical Research Management Course: How to Use Metrics Effectively to Gain Real, Actionable Insights Into the Progress of Your Clinical Research Projects (ONLINE)

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Measuring Performance in Clinical Research Management (May 6, 2026)" training has been added to ResearchAndMarkets.com's offering. This...
April 14, 2026 10:59 ET | Source: Research and Markets

Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Drug Development Services Market Report 2026" has been added to ResearchAndMarkets.com's offering. The drug development services market has...
April 14, 2026 03:26 ET | Source: Mordor Intelligence

Cell Line Development Market to Reach $8.95 Bn by 2031 with Gene & Cell Therapy Manufacturing Growing at 10.88% CAGR, Says Mordor Intelligence

Cell line development market driven by biologics, mAbs and gene therapies, with innovation and automation led by Thermo Fisher, Merck, Danaher, Lonza.
April 02, 2026 08:07 ET | Source: Curanex Pharmaceuticals Inc

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals, Inc. (Nasdaq: CURX)...
April 01, 2026 13:47 ET | Source: BCC Research LLC

Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand

Increasing adoption of cloud platforms is enabling scalable data analysis, accelerating genomics research, and streamlining drug development workflows.
March 30, 2026 11:12 ET | Source: Mordor Intelligence

AI in Drug Discovery Market to Hit USD 10.29 Bn by 2031 with Quantum Machine Learning Advancing Rapidly at 27%+ CAGR - Mordor Intelligence Report

Hyderabad, India, March 30, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the artificial intelligence in drug discovery market size was valued at USD 2.58 billion in 2025 and is...
March 30, 2026 02:00 ET | Source: Draupnir Bio

Draupnir Bio announces transformational publication detailing extracellular targeted protein degradation technology in Cell Chemical Biology

Draupnir’s novel SORTAC platform expands reach of targeted protein degradation to extracellular proteins, demonstrating in vitro and in vivo efficacy against difficult-to-drug targetsStudy further...
March 23, 2026 11:46 ET | Source: ProductLife Group (PLG)

Dr. James Burt Joins ProductLife Group as CEO

ProductLife Group appoints Dr. James Burt as CEO, strengthening global growth and capabilities across regulatory, clinical, quality and digital services.